Buttgereit F - Search Results

1

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.

Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW. Duru N, et al. Among authors: buttgereit f. Ann Rheum Dis. 2013 Dec;72(12):1905-13. doi: 10.1136/annrheumdis-2013-203249. Epub 2013 Jul 19. Ann Rheum Dis. 2013. PMID: 23873876 Free article.

2

Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.

Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR, Buttgereit F. Sanden S, et al. Among authors: buttgereit f. J Rheumatol. 2000 May;27(5):1265-70. J Rheumatol. 2000. PMID: 10813299

3

Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.

Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Köhler L, Van Riel P, Vischer T, Bijlsma JW. Buttgereit F, et al. Ann Rheum Dis. 2002 Aug;61(8):718-22. doi: 10.1136/ard.61.8.718. Ann Rheum Dis. 2002. PMID: 12117678 Free PMC article.

4

Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment.

Kuhnke A, Burmester GR, Krauss S, Buttgereit F. Kuhnke A, et al. Among authors: buttgereit f. Ann Rheum Dis. 2003 Feb;62(2):133-9. doi: 10.1136/ard.62.2.133. Ann Rheum Dis. 2003. PMID: 12525382 Free PMC article.

5

Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.

Loddenkemper K, Grauer A, Burmester GR, Buttgereit F. Loddenkemper K, et al. Among authors: buttgereit f. Clin Exp Rheumatol. 2003 Jan-Feb;21(1):19-26. Clin Exp Rheumatol. 2003. PMID: 12673885 Clinical Trial.

6

Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action.

Buttgereit F, Straub RH, Wehling M, Burmester GR. Buttgereit F, et al. Arthritis Rheum. 2004 Nov;50(11):3408-17. doi: 10.1002/art.20583. Arthritis Rheum. 2004. PMID: 15529366 Free article. Review. No abstract available.

7

Which dose regimen for glucocorticoid pulse therapy in patients with severe refractory RA?

Buttgereit F, Burmester G, Bijlsma JW. Buttgereit F, et al. Ann Rheum Dis. 2005 Jan;64(1):171-2; author reply 172. Ann Rheum Dis. 2005. PMID: 15608329 Free PMC article. No abstract available.

8

Developments in glucocorticoid therapy.

Bijlsma JW, Saag KG, Buttgereit F, da Silva JA. Bijlsma JW, et al. Among authors: buttgereit f. Rheum Dis Clin North Am. 2005 Feb;31(1):1-17, vii. doi: 10.1016/j.rdc.2004.10.003. Rheum Dis Clin North Am. 2005. PMID: 15639052 Review.

9

Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.

Straub RH, Sarzi-Puttini P, Atzeni F, Buttgereit F, Carrabba M, Cutolo M. Straub RH, et al. Among authors: buttgereit f. Ann Rheum Dis. 2005 Sep;64(9):1353-6. doi: 10.1136/ard.2004.031997. Epub 2005 Feb 11. Ann Rheum Dis. 2005. PMID: 15708882 Free PMC article.

10

Optimised glucocorticoid therapy: the sharpening of an old spear.

Buttgereit F, Burmester GR, Lipworth BJ. Buttgereit F, et al. Lancet. 2005 Feb 26-Mar 4;365(9461):801-3. doi: 10.1016/S0140-6736(05)17989-6. Lancet. 2005. PMID: 15733723 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page